Inventor
LINGYUN WU
Inventor
CN
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes23%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
LOC132%
LOC142%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
12,492,215Pyrrolotriazine compounds acting as MNK inhibitor202512,479,794Acetophenone oxime compound and application thereof202512,459,918Isoquinolinone derivatives serving as rock protein kinase inhibitors and use thereof202512,365,686Compound as porcupine inhibitor and use thereof202512,024,494Salt of LSD1 inhibitor and a polymorph thereof202411,760,751Benzo 2-azaspiro[4.4]nonane compound and use thereof2023D0996436Docking station202311,702,400Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors202311,649,245Cyclopropylamine compound as LSD1 inhibitor and use thereof202311,524,941Pyrazole compounds as LSD1 inhibitors and applications thereof2022D0971138Charging dock for VR headset202211,465,995Crystal and salt forms of tricyclic compound and preparation process thereof202211,433,053LSD1 inhibitor and preparation method and application thereof202211,390,625Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor2022RE049128Hydroxyl purine compounds and applications thereof202211,345,678Benzopyrazole compound used as RHO kinase inhibitor202211,192,886S1P1 agonist and application thereof202111,155,559Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to MEDSHINE DISCOVERY INC (7)· patent assignee history
2021–2025Based in CN· patent location history
2022–2024Patents assigned to CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (2)· patent assignee history
2022Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (1)· patent assignee history
2023Patents assigned to HELIOEAST PHARMACEUTICAL CO LTD (2)· patent assignee history
2023Patents assigned to HELIOEAST SCIENCE & TECH CO LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MEDSHINE DISCOVERY INC | 7 | 2021–2025 |
| CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD | 2 | 2022–2024 |
| HELIOEAST PHARMACEUTICAL CO LTD | 2 | 2023 |
| HELIOEAST SCIENCE & TECH CO LTD | 2 | 2023 |
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 18 | 2021–2025 |